A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls

Autor: Anna Bahí, Marta Malagón, David Busquets, Jordi Serra, J O Miquel-Cusachs, Miriam Sàbat, Fiorella Cañete, Xavier Aldeguer, Librado Jesús Garcia‐Gil, Joan Amoedo, Fermín Mearin, Ingrid Marin, Sara Ramió-Pujol, Javier Santos, Alan C. Moss, Marta Serrano, Jordi Guardiola, Eugeni Domènech, Ariadna Clos, Paola Torres, Míriam Mañosa, Pau Gilabert, Gemma Ibáñez-Sanz, Mariona Serra-Pagès, Leyanira Torrealba

Publikováno v: GastroHep: an international journal of gastroenterology and hepatplogy, 2020, vol. 2, núm. 5, p. 193-204
Articles publicats (D-B)
DUGiDocs – Universitat de Girona
instname

Background Irritable bowel syndrome (IBS) is a functional disorder affecting around 11% of the world population, which diagnostic is mainly based on clinical parameters. IBS shares many symptoms with other gastrointestinal disorders such as inflammat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a287415ebf7485b96a027361edfe4a
https://doi.org/10.1002/ygh2.417

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Autor: J O Miquel-Cusachs, Antoni Castells, Xavier Queralt-Moles, Anna Bahí, Lia Oliver, Pau Gilabert, Jordi Guardiola, Virginia Piñol, Manel Ramirez, L. Jesús Garcia-Gil, Joan Saló, Xavier Aldeguer, Mariona Serra-Pagès, Marta Serrano, Joan Amoedo, Marta Malagón, Sara Ramió-Pujol

Publikováno v: PLoS One, 2020, vol. 15, núm. 12, p. e0243158
Articles publicats (D-B)
Malagón Rodríguez, Marta Ramió Pujol, Sara Serrano, Marta Amoedo, Joan Oliver, Lia Bahí, Anna Miquel Cusachs, Josep Oriol Ramírez, Manel Queralt Moles, Xavier Gilabert, Pau Saló, Joan Guardiola, Jordi Piñol Sánchez, Virgínia Serra Pagès, Mariona Castells, Antoni Aldeguer i Manté, Xavier Garcia-Gil, L. J. 2020 New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population PLoS One 15 12 e0243158
DUGiDocs – Universitat de Girona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0243158 (2020)
PLoS ONE

Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270f9f289880df742de405b2cc8c932
http://hdl.handle.net/10256/18762

P674 Definition of a microbial signature as a predictor of anti-TNFα treatment response

Autor: Jesús Garcia-Gil, Xavier Aldeguer, Lia Oliver, J O Miquel-Cusachs, David Busquets, Miriam Sàbat, Marta Serrano, Anna Bahí, Pau Gilabert, Mariona Serra-Pagès, Sara Ramió-Pujol, Jordi Guardiola, A Lluansí, Joan Amoedo, Marta Malagón

Publikováno v: Journal of Crohn's and Colitis. 15:S595-S595

Background Crohn’s disease (CD) and ulcerative colitis (UC) evolve with alternate outbreaks and remissions of variable duration. Tumour necrosis factor α antagonists (anti-TNFα) have enhanced the treatment of patients with inflammatory bowel dise

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79f693f328600d65228da7719031009b
https://doi.org/10.1093/ecco-jcc/jjab076.794

P835 Correlation between microbial markers and faecal calprotectin in IBD patients

Autor: Xavier Aldeguer, Miriam Sàbat, J O Miquel-Cusachs, Anna Bahí, J Amoedo Cibeira, Lia Oliver, Sara Ramió-Pujol, Míriam Mañosa, Leyanira Torrealba, David Busquets, Pau Gilabert, Jesús Garcia-Gil, C Puig-Amiel, E. Domènech, Jordi Guardiola, Mariona Serra-Pagès, Ariadna Clos, Fiorella Cañete

Publikováno v: Journal of Crohn's and Colitis. 14:S648-S648

Background Crohn disease (CD) and Ulcerative colitis (UC) are characterised by episodes of exacerbations and remissions. Monitoring disease activity based on intestinal lesion is mandatory prior to any change in the therapeutic strategy. Colonoscopy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b6674ddec00ca0c714f7872b135da07
https://doi.org/10.1093/ecco-jcc/jjz203.963

HEMOSPRAY: DESCRIPTIVE STUDY ABOUT ITS APPLICATION ON GASTROINTESTINAL BLEEDING IN A UNIVERSITY HOSPITAL

Autor: Marc Albert, Xavier Aldeguer, I Serra, L Peries, C Luz Rosales, RF Louvrieux, Carlos Huertas, O Retto, Leyanira Torrealba, David Busquets, H Ikuo Uchima, C Coll, O. Miquel

Publikováno v: ESGE Days 2018 accepted abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::723f86b6cd502958f6e7d820ba48da25
https://doi.org/10.1055/s-0038-1637425